← Open Payments lookup

DANIELLE DOEBEREINER-BROWN: Open Payments

NPI 1225564917 · CARROLLTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$383 in 14 payments from 8 companies in 2025. Trend: 2023 $236 · 2024 $364 · 2025 $383

Food & beverage: $383
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP1$121
Novo Nordisk Inc4$72
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$63
Takeda Pharmaceuticals U.S.A., Inc.2$48
GlaxoSmithKline, LLC.1$24
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$23
Lilly USA, LLC1$19
ABBVIE INC.1$15

Products named: TEZSPIRE, CAPLYTA, ENTYVIO, Wegovy, SHINGRIX, XIFAXAN, JARDIANCE, Ozempic.

Industry payments across GA — which companies pay providers there.